Cited 0 times in
Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:47:07Z | - |
dc.date.available | 2023-06-02T00:47:07Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194426 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | A. Bardia | - |
dc.contributor.googleauthor | K. Kalinsky | - |
dc.contributor.googleauthor | J. Tsurutani | - |
dc.contributor.googleauthor | E.P. Hamilton | - |
dc.contributor.googleauthor | S. Johnston | - |
dc.contributor.googleauthor | J. Sohn | - |
dc.contributor.googleauthor | K.H. Park | - |
dc.contributor.googleauthor | Y.H. Park | - |
dc.contributor.googleauthor | S-A. Im | - |
dc.contributor.googleauthor | K.S. Lee | - |
dc.contributor.googleauthor | D. Dastur | - |
dc.contributor.googleauthor | V. Haddad | - |
dc.contributor.googleauthor | S. Khan | - |
dc.contributor.googleauthor | B. Xu | - |
dc.contributor.googleauthor | B. Pistilli | - |
dc.contributor.googleauthor | H.S. Rugo | - |
dc.identifier.doi | 10.1016/j.annonc.2022.07.1858 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422037097 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 7 | - |
dc.citation.startPage | S663 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 7) : S663, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.